Behzad Baradaran

3.9k total citations · 3 hit papers
113 papers, 2.9k citations indexed

About

Behzad Baradaran is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Behzad Baradaran has authored 113 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 41 papers in Oncology and 40 papers in Cancer Research. Recurrent topics in Behzad Baradaran's work include MicroRNA in disease regulation (33 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Circular RNAs in diseases (21 papers). Behzad Baradaran is often cited by papers focused on MicroRNA in disease regulation (33 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Circular RNAs in diseases (21 papers). Behzad Baradaran collaborates with scholars based in Iran, Italy and Denmark. Behzad Baradaran's co-authors include Ahad Mokhtarzadeh, Fatemeh Oroojalian, Mohammad‐Ali Shahbazi, Mohammad Amini, M H Miran Beygi, Nicola Silvestris, Mahdi Abdoli Shadbad, Behzad Mansoori, Ali Mohammadi and Oronzo Brunetti and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Behzad Baradaran

108 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune Cell Membrane‐Coated Biomimetic Nanoparticles for Targeted Cancer Therapy

2021 388 citations Fatemeh Oroojalian, Behzad Baradaran et al. profile →
Recent advances in nanoparticle-based photothermal therapy for breast cancer

2022 204 citations Mohammad Amini, Nazila Jalilzadeh et al. Journal of Controlled Release profile →
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies

2023 124 citations Amin Daei Sorkhabi, Leila Mohamed Khosroshahi et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Behzad Baradaran Iran	28	1.4k	773	757	664	659	113	2.9k
Xiaodong Xie China	32	1.7k 1.2×	506 0.7×	625 0.8×	614 0.9×	465 0.7×	141	3.2k
Shuzhong Cui China	25	1.4k 1.0×	699 0.9×	668 0.9×	884 1.3×	455 0.7×	91	2.9k
Ling Ding China	36	2.2k 1.6×	589 0.8×	662 0.9×	800 1.2×	729 1.1×	135	4.2k
Tahereh Javaheri Austria	16	1.1k 0.8×	514 0.7×	780 1.0×	547 0.8×	434 0.7×	22	2.4k
Joshua A. McCarroll Australia	30	2.1k 1.5×	560 0.7×	1.3k 1.7×	581 0.9×	382 0.6×	61	4.0k
Xiaoyu Liang China	28	1.3k 1.0×	561 0.7×	454 0.6×	422 0.6×	853 1.3×	65	2.7k
Lixia Yu China	33	1.7k 1.3×	688 0.9×	859 1.1×	613 0.9×	431 0.7×	145	3.3k
Meng Yang China	22	1.3k 0.9×	493 0.6×	787 1.0×	317 0.5×	306 0.5×	58	2.8k
Arati Sharma United States	30	2.5k 1.8×	424 0.5×	1.1k 1.4×	399 0.6×	721 1.1×	90	3.9k
Ruifang Niu China	38	2.5k 1.9×	417 0.5×	969 1.3×	972 1.5×	413 0.6×	87	3.9k

Countries citing papers authored by Behzad Baradaran

Since Specialization

Citations

This map shows the geographic impact of Behzad Baradaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behzad Baradaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behzad Baradaran more than expected).

Fields of papers citing papers by Behzad Baradaran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behzad Baradaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behzad Baradaran. The network helps show where Behzad Baradaran may publish in the future.

Co-authorship network of co-authors of Behzad Baradaran

This figure shows the co-authorship network connecting the top 25 collaborators of Behzad Baradaran. A scholar is included among the top collaborators of Behzad Baradaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behzad Baradaran. Behzad Baradaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mohammadzadeh, Reza, et al.. (2025). Improvement of carboplatin chemosensitivity in lung cancer cells by siRNA-mediated downregulation of DLGAP1-AS2 expression. Scientific Reports. 15(1). 7971–7971. 1 indexed citations

Baradaran, Behzad, et al.. (2024). In vitro effects of crocin on the possible anticancer properties of Lactococcus lactis against colorectal adenocarcinoma cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(5). 5729–5741. 2 indexed citations

Baradaran, Behzad, et al.. (2024). Hydroxychloroquine-Mediated Autophagy Inhibition Shifts Monocyte-Derived Dendritic Cells Toward Immunogenic Phenotype In Vitro. South Eastern European Journal of Public Health. 673–680.

Sorkhabi, Amin Daei, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.. (2023). The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies. Frontiers in Immunology. 14. 1113882–1113882. 124 indexed citations breakdown →

Feizi, Mohammad Ali Hosseinpour, et al.. (2023). Serum Levels of Long Non-coding RNAs NEAT1, GAS5, and GAPLINCAltered in Rheumatoid Arthritis. Current Rheumatology Reviews. 20(2). 182–190. 2 indexed citations

Safaralizadeh, Reza, et al.. (2023). The effect of glatiramer acetate, IFNβ-1a, fingolimod, and dimethyl fumarate on the expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS patients. BMC Research Notes. 16(1). 273–273.

Amini, Mohammad, et al.. (2023). MicroRNA-425: A Pivotal Regulator Participating in Tumorigenesis of Human Cancers. Molecular Biotechnology. 66(7). 1537–1551. 3 indexed citations

Asadzadeh, Zahra, Amir Baghbanzadeh, Afshin Derakhshani, et al.. (2022). The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment. Frontiers in Immunology. 13. 938063–938063. 7 indexed citations

Alibakhshi, Abbas, Miguel de la Guárdia, Behzad Baradaran, et al.. (2022). Conductive and Semiconductive Nanocomposite‐Based Hydrogels for Cardiac Tissue Engineering. Advanced Healthcare Materials. 11(18). e2200526–e2200526. 64 indexed citations

10.

Safaei, Sahar, Mohammad Amini, Ahad Mokhtarzadeh, et al.. (2022). miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene. Experimental and Molecular Pathology. 125. 104753–104753. 25 indexed citations

11.

Amini, Mohammad, Nazila Jalilzadeh, Behzad Baradaran, et al.. (2022). Recent advances in nanoparticle-based photothermal therapy for breast cancer. Journal of Controlled Release. 349. 269–303. 204 indexed citations breakdown →

12.

Sorkhabi, Amin Daei, Aila Sarkesh, Hossein Saeedi, et al.. (2022). The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme. Frontiers in Oncology. 12. 818447–818447. 14 indexed citations

13.

Dastmalchi, Narges, Reza Safaralizadeh, Mohammad Ali Hosseinpour Feizi, Behzad Baradaran, & Seyed Mahdi Banan Khojasteh. (2021). MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation. Molecular Biology Reports. 48(2). 1345–1357. 26 indexed citations

14.

Mokhtarzadeh, Ahad, et al.. (2021). Effects of PEI-PEG Nanoparticles Loaded With CD44 siRNA on Inhibition of Growth, Invasion, and Migration of Glioblastoma Cells. SHILAP Revista de lepidopterología. 2 indexed citations

15.

Shadbad, Mahdi Abdoli, Negar Hosseinkhani, Zahra Asadzadeh, et al.. (2021). The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI: A Meta-Analysis. Frontiers in Oncology. 11. 722833–722833. 13 indexed citations

16.

Doustvandi, Mohammad Amin, et al.. (2021). MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy. Reproductive Sciences. 28(7). 2036–2049. 15 indexed citations

17.

Faghfouri, Amir Hossein, Behzad Baradaran, Alireza Khabbazi, et al.. (2021). Invited letter to editor in response to profiling inflammatory cytokines following zinc supplementation: a systematic review and meta-analysis of randomised controlled trials. British Journal Of Nutrition. 127(3). 479–480. 1 indexed citations

18.

Zarrini, Gholamreza, Behzad Baradaran, Gholamreza Hamidian, et al.. (2020). Heat killed Dietzia maris reduces lipopolysaccharide-induced inflammatory responses in murine adherent peritoneal cells. ΙΝΣΤΙΤΟΥΤΟ ΙΣΤΟΡΙΚΩΝ ΕΡΕΥΝΩΝ (National Hellenic Research Foundation).

19.

Hosseini, Arezoo, Zohreh Babaloo, Tohid Gharibi, et al.. (2020). Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease. BMC Research Notes. 13(1). 568–568. 12 indexed citations

20.

Baradaran, Behzad, et al.. (2017). MICRORNA-145 INHIBITS MIGRATION OF HUMAN NON-SMALL-CELL LUNG CANCER (A549). 28(5). 321–331. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact